HealthInvestor Executive Moves
Remember me:
HealthInvestor Executive moves The latest appointments in the independent healthcare industry

BVCA: Michael Moore

The British Private Equity & Venture Capital Association (BVCA) has appointed Michael Moore (pictured), former Liberal Democrat MP and Scottish secretary of state, as its new director general.

Moore succeeds Tim Hames and will take up the position later this year.

Currently a senior advisor at PwC, specialising in government and public policy, Moore is a chartered accountant who previously worked in corporate finance.

Moore was elected as MP for the Tweeddale, Ettrick and Lauderdale constituency in the Scottish Borders in 1997 and joined the party’s front bench in 2005. He was Secretary of State for Scotland in the coalition government between 2010 and 2013 and later served as European business adviser to the deputy prime minister until leaving Parliament at the 2015 general election. 

Calum Paterson, chairman of BVCA, said: “We have been fortunate to have had an outstanding director general in Tim Hames over the last six years. He has been a great ambassador for private equity and venture capital and has fulfilled his role with great distinction. Identifying a worthy successor was never going to be an easy task, but we are delighted to have appointed Michael Moore.  

“Michael brings exceptional credentials and experience in both business and politics. He has an intimate knowledge of Westminster and government, is a first-class communicator and has also had direct experience of working with the private equity and venture capital sector in his role at PwC. I am confident that he will be an excellent leader of the BVCA at this important time for our industry and for UK business more generally.”

Moore said: “I am very much looking forward to joining the BVCA and to supporting the private equity and venture capital industry in the invaluable work it does across the UK. The broader economic impact of the industry is extremely important in terms of employment, innovation and economic growth. I look forward to playing my part in ensuring that the crucial role it plays is fully understood and valued.”

Posted on: 27/03/2019

Latest news stories

In Scotland, more people have died from Covid-19 in care homes than in hospital, according to the latest official figures.
UK primary care REIT Assura is set to start work this month on a new GP surgery in Ware, Hertfordshire.
Elysium Neurological, part of Elysium Healthcare, has opened a specialised neurobehavioural rehabilitation service for adults in Swindon.
DenScreen, a partnership between dental and infectious disease experts, has launched a new service to tackle and minimise the risk of Covid-19 in the dental workplace.
The government’s abrupt decision announced at the weekend that 2.2 million people in England with medical conditions that put them at greater risk from Covid-19 can now leave their homes has left patients anxious and confused.

HealthInvestor Feature

Consultant profile

Introducing: Ben Westcott

Ben has an extensive background partnering leading providers within the independent health, social care and specialist education sectors. The associated knowledge, network and credibility this has generated has resulted in numerous C-suite and Board-level hires.

Ben’s most recent work spans: Private Acute Hospitals; Specialist Care; Care Homes; Children’s Services; Primary Care; Diagnostics; and Mental Health Hospitals, where he has led some of the most recognised sector appointments in recent months.

He has developed a reputation for his outstanding delivery and results, evidenced by the number of testimonials he has received commenting specifically on his exceptional service levels.

Recently completed mandates:

  • CEO | Private acute | International investors
  • CEO | Specialist Care | Charity
  • COO | Domiciliary Care | PE
  • CEO | Benevolent Fund | Charity
  • COO | Elderly Care | UK PE
Compass Executives
To find out more about Ben, or to contact him about new opportunities, please contact or call 07900 254 285.

2019 InvestorPublishing.